The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

Update on primary HPV screening for cervical cancer prevention

AE Rizzo, S Feldman - Current problems in cancer, 2018 - Elsevier
In the coming decade, primary testing for human papillomavirus (HPV) will likely become the
standard of care for cervical cancer screening in both low-and high-resource settings. This …

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …

JB Lew, KT Simms, MA Smith, M Hall… - The Lancet Public …, 2017 - thelancet.com
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …

Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV

MT Hall, KT Simms, JM Murray, A Keane… - Nature Medicine, 2023 - nature.com
To support a strategy to eliminate cervical cancer as a public health problem, the World
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point …

DTN Nguyen, KT Simms, A Keane, G Mola… - BMJ global …, 2022 - gh.bmj.com
Introduction WHO has launched updated cervical screening guidelines, including provisions
for primary HPV screen-and-treat. Papua New Guinea (PNG) has a high burden of cervical …

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

MA Smith, M Sherrah, F Sultana, PE Castle, M Arbyn… - bmj, 2022 - bmj.com
Objective To review the first two years of the primary human papillomavirus (HPV) cervical
screening programme in an HPV vaccinated population. Design Observational study …

[HTML][HTML] Natural and synthetic drugs and formulations for intravaginal HPV clearance

NA Khamjan, S Beigh, A Algaissi, K Megha… - Journal of Infection and …, 2023 - Elsevier
Background Except for a few preventative Human Papillomavirus (HPV) vaccines, there is
currently no cure for HPV infection. There are a number of cutting-edge strategies and potent …

[HTML][HTML] Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the …

PJ Toliman, JM Kaldor, SG Badman, J Gabuzzi… - Papillomavirus …, 2018 - Elsevier
The performance of different clinical screening algorithms comprising point-of-care HPV-
DNA testing using self-collected vaginal ('V') specimens, and visual inspection of the cervix …

[HTML][HTML] Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study

S Kaljouw, EEL Jansen, CA Aitken, LM Harrijvan… - Gynecologic …, 2021 - Elsevier
Background With the implementation of primary high-risk human papillomavirus (hrHPV)
screening in the Netherlands, an increase was observed in the number of unnecessary …